Tivic health announces successful completion of non-invasive vagus nerve stimulation study (vns); demonstrates clinically effective biological changes in the autonomic, cardiac, and central nervous systems

San francisco--(business wire)--tivic health® systems, inc. (“tivic health”, nasdaq: tivc), a health tech company that develops and commercializes bioelectronic medicine, announced today the final results of their pilot research study with the feinstein institutes for medical research at northwell health. through this collaboration, tivic health has confirmed the effectiveness of its patent-pending non-invasive cervical vagus nerve stimulation (ncvns) approach, which induces responses in the au.
TIVC Ratings Summary
TIVC Quant Ranking